Early treatment of cavernositis resulted in erectile function preservation.
BACKGROUND
Some of the more common complications of intracavernous injection (ICI) therapy include pain and prolonged erections. Rare reported complications include intracorporeal needle breakage and postinjection cavernositis.


OBJECTIVE
We report a case of early management of postinjection cavernositis resulting in preservation of erectile function with no angulation.


METHODS
A 53-year-old male with no history of diabetes mellitus presented to our department with a small painful penile swelling 36 hours after ICI of 15 microg prostaglandin E1. Clinical, laboratory, and ultrasound assessments suggested the occurrence of cavernositis. Surgical debridement, abscess drainage, and antibiotics resulted in marked improvement. Follow-up showed normal erectile function with minimal scarring.


CONCLUSIONS
Timely management of cavernositis can help prevent loss of erectile function. Stringent supervision of patients, after adequate ICI training, together with drug prescription, is essential.
Shamloul
Rany
R
Department of Andrology, Sexology & STDs, Cairo University, Cairo, Egypt. rannone74@hotmail.com
Kamel
Ihab
I
D000527:Alprostadil / Q000009:adverse effects; D000890:Anti-Infective Agents / Q000008:administration & dosage; D001442:Bacteroides Infections / Q000175:diagnosis* / Q000188:drug therapy* / Q000382:microbiology; D007172:Erectile Dysfunction / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control*; D006801:Humans; D015552:Injections, Intralesional / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D010413:Penis / Q000000981:diagnostic imaging / Q000382:microbiology; D011472:Prostatitis / Q000178:diet therapy / Q000188:drug therapy* / Q000382:microbiology*; D014463:Ultrasonography; D014665:Vasodilator Agents / Q000009:adverse effects
D000890:Anti-Infective Agents; D014665:Vasodilator Agents; D000527:Alprostadil